By proceeding, you agree to our Terms of Use and Privacy Policy.
The 2nd Ligase Targeting Drug Development Summit returns with new insight and data from pioneers in the field to delve deep into ligase biology, assays to investigate functions as well as screening tools for optimum ligand identification and validation.
Meet 30+ Industry Leaders as they speak about leveraging Cell and Tissue specific Ubiquitin E3 ligases for degradation or modulation of targets of interest.
Know functions of Ubiquitin Ligases, improve Specificity and speed-up Ligand Discovery to bring forth E3-Targeting Therapeutics for Protein degradation & modulations.
Network with 150+ seasoned attendees, over 25+ incisive sessions and 3 interactive workshops at this ground-breaking scientific Event.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.